Studies of harm. Clinical applications.

Rev Port Cardiol

Centro de Estudos de Medicina Baseada na Evidência Faculdade de Medicina de Lisboa, Lisboa, Portugal.

Published: May 2005

When a clinician institutes a therapy, he/she has to consider, besides its efficacy, the harm a substance that is foreign to the body may cause. Nowadays, with the number of drugs available, more and more iatrogenic events are occurring, to the extent that the term 'iatroepidemic' has been coined to describe the phenomenon. Harm can be assessed by experimental studies, but this design raises ethical as well as financial issues, so the best evidence is gathered from observational data, mainly case-control and cohort studies. In previous articles we discussed the methodology to evaluate therapeutic benefit. In this article we aim to review designs for determining harm.

Download full-text PDF

Source

Publication Analysis

Top Keywords

studies harm
4
harm clinical
4
clinical applications
4
applications clinician
4
clinician institutes
4
institutes therapy
4
therapy he/she
4
he/she consider
4
consider efficacy
4
efficacy harm
4

Similar Publications

Bridging the gap: Evaluating ChatGPT-generated, personalized, patient-centered prostate biopsy reports.

Am J Clin Pathol

January 2025

Department of Pathology and Laboratory Medicine, NorthShore/Endeavor Health, Evanston, IL, United States.

Objective: The highly specialized language used in prostate biopsy pathology reports coupled with low rates of health literacy leave some patients unable to comprehend their medical information. Patients' use of online search engines can lead to misinterpretation of results and emotional distress. Artificial intelligence (AI) tools such as ChatGPT (OpenAI) could simplify complex texts and help patients.

View Article and Find Full Text PDF

Objective: Alcohol and Other Drug (AOD) disorders cause substantial harm. Effective Substance Use Treatment (SUT) exists, but long-term outcomes remain inconclusive. This study used a 20-year prospective follow-up of 1248 service users entering SUT in Stockholm, Sweden, in 2000-2002 to elaborate on how different dimensions of long-term outcomes may be measured by register-based indicators.

View Article and Find Full Text PDF

Frequency of consumption and factors associated with hookah use in Curitiba, Brazil: a cross-sectional study.

BMC Public Health

January 2025

Escola de Medicina e Ciências da Vida, Pontifícia Universidade Católica do Paraná, Imaculada Conceição, 1155, Prado Velho, Curitiba, PR, CEP 8021, Brazil.

Objective: To analyze the consumption frequency and factors associated with hookah usage.

Methods: This cross-sectional study involved adults, hookah users, residing in the city of Curitiba. Hookah groups were contacted on social networking sites via an invitation that contained a link to the questionnaire, which comprised 21 questions covering demographic and socioeconomic characteristics, user profiles, use of cigarettes and alcohol, symptoms, and perceptions of the risks of hookah use.

View Article and Find Full Text PDF

'If one doesn't happen, the other will': forensic mental health service patients' experiences of co-occurring self-harm and aggression.

BJPsych Open

January 2025

Division of Psychology and Mental Health, School of Health Sciences, Manchester Academic Health Science Centre, University of Manchester, Manchester, UK.

Background: Co-occurring self-harm and aggression (dual harm) is particularly prevalent among forensic mental health service (FMHS) patients. There is limited understanding of why this population engages in dual harm.

Aims: This work aims to explore FMHS patients' experiences of dual harm and how they make sense of this behaviour, with a focus on the role of emotions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!